FDG PET/CT in ovarian cancer: what about treatment response and prognosis?
Clin Nucl Med
.
2012 Jan;37(1):54-6.
doi: 10.1097/RLU.0b013e3182336126.
Authors
Gaia Grassetto
1
,
David Groheux
,
Maria Cristina Marzola
,
Elif Hindié
,
Adil Al-Nahhas
,
Domenico Rubello
Affiliation
1
Department of Nuclear Medicine, PET/CT Centre, Santa Maria della Misericordia Hospital, Rovigo, Italy.
[email protected]
PMID:
22157029
DOI:
10.1097/RLU.0b013e3182336126
No abstract available
Publication types
Comment
MeSH terms
Female
Fluorodeoxyglucose F18*
Humans
Ovarian Neoplasms / classification*
Ovarian Neoplasms / diagnosis*
Positron-Emission Tomography / methods*
Tomography, X-Ray Computed / methods*
Substances
Fluorodeoxyglucose F18